Record overview
Status and phase
Status: WITHDRAWN
Phase: PHASE2
Sponsor: RemeGen Co., Ltd.
Condition: Breast Neoplasms
NCT06105008
Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
Due to the company's strategic adjustment (non-security related)